Sana Biotechnology (SANA)

• Market cap: $904M
• 1 day: 2.52%
• 5 days: 1.25%
• 1 month: -6.88%
• 3 months: -1.22%
• 6 months: -26.64%
• Year to date: -22.43%
• 1 year: -25.46%
• 5 years: -80.05%
• 10 years: -90.74%
• Sector: Healthcare
• Industry: Biotechnology

About: Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.

Employees: 142